InsiderClue
Insiders · Profile

Nashat Amir

Director at Camp4 Therapeutics · Director at Scholar Rock · Director at FATE THERAPEUTICS · and 1 more. Filing since 4 Oct 2013. CIK 0001575843

CAMP Camp4 Therapeutics Corp Director · 2 trades SRRK Scholar Rock Holding Corp Director · 2 trades FATE FATE THERAPEUTICS INC Director · 24 trades RNAC Cartesian Therapeutics, Inc. Director · 7 trades
Company
Date
Role
Action
Shares
Amount
Of holding
CAMP Camp4 Therapeutics Corp
11 Sep 2025
Director
Bought
1,307,189
$2.00M
86.1%
CAMP Camp4 Therapeutics Corp
15 Oct 2024
Director
Bought
909,090
$10.00M
opened
SRRK Scholar Rock Holding Corp
22 Jun 2022
Director
Bought
1,197,992
$5.87M
51.1%
FATE FATE THERAPEUTICS INC
1 Aug 2019
Director
Sold, plan not stated
30,866
$695.39K
80.4%
FATE FATE THERAPEUTICS INC
31 Jul 2019
Director
Sold, plan not stated
31,139
$701.67K
80.1%
FATE FATE THERAPEUTICS INC
30 Jul 2019
Director
Sold, plan not stated
90,175
$2.03M
91.9%
FATE FATE THERAPEUTICS INC
29 Jul 2019
Director
Sold, plan not stated
329
$7.40K
3.7%
FATE FATE THERAPEUTICS INC
26 Jul 2019
Director
Sold, plan not stated
27,829
$626.15K
76.5%
FATE FATE THERAPEUTICS INC
24 Jul 2019
Director
Sold, plan not stated
19,866
$447.10K
69.5%
FATE FATE THERAPEUTICS INC
23 Jul 2019
Director
Sold, plan not stated
62,033
$1.40M
87.5%
FATE FATE THERAPEUTICS INC
22 Jul 2019
Director
Sold, plan not stated
48,704
$1.10M
84.0%
FATE FATE THERAPEUTICS INC
19 Jul 2019
Director
Sold, plan not stated
1,053
$23.69K
9.9%
FATE FATE THERAPEUTICS INC
18 Jul 2019
Director
Sold, plan not stated
21,409
$481.79K
69.0%
FATE FATE THERAPEUTICS INC
30 Jan 2019
Director
Sold, plan not stated
53,017
$750.96K
3.5%
FATE FATE THERAPEUTICS INC
29 Jan 2019
Director
Sold, plan not stated
97,500
$1.38M
6.0%
FATE FATE THERAPEUTICS INC
28 Jan 2019
Director
Sold, plan not stated
70,000
$964.77K
4.1%
RNAC Cartesian Therapeutics, Inc.
25 Jan 2019
Director
Bought
1,166,666
$1.75M
77.3%
FATE FATE THERAPEUTICS INC
25 Jan 2019
Director
Sold, plan not stated
90,000
$1.27M
5.0%
FATE FATE THERAPEUTICS INC
18 Jan 2019
Director
Sold, plan not stated
39,483
$642.83K
2.2%
FATE FATE THERAPEUTICS INC
20 Dec 2018
Director
Sold, plan not stated
33,474
$410.16K
1.8%
FATE FATE THERAPEUTICS INC
19 Dec 2018
Director
Sold, plan not stated
91,210
$1.22M
4.7%
FATE FATE THERAPEUTICS INC
13 Dec 2018
Director
Sold, plan not stated
17,788
$296.56K
0.9%
FATE FATE THERAPEUTICS INC
12 Dec 2018
Director
Sold, plan not stated
425,000
$7.13M
17.8%
FATE FATE THERAPEUTICS INC
11 Dec 2018
Director
Sold, plan not stated
82,528
$1.38M
3.3%
SRRK Scholar Rock Holding Corp
29 May 2018
Director
Bought
142,857
$2.00M
5.6%
RNAC Cartesian Therapeutics, Inc.
26 Sep 2017
Director
Sold, plan not stated
70,226
$1.33M
86.9%
RNAC Cartesian Therapeutics, Inc.
25 Sep 2017
Director
Sold, plan not stated
37,175
$705.88K
77.0%
RNAC Cartesian Therapeutics, Inc.
22 Sep 2017
Director
Sold, plan not stated
42,036
$809.78K
78.8%
RNAC Cartesian Therapeutics, Inc.
21 Sep 2017
Director
Sold, plan not stated
104,577
$2.08M
90.0%
RNAC Cartesian Therapeutics, Inc.
20 Sep 2017
Director
Sold, plan not stated
42,610
$853.39K
77.6%
RNAC Cartesian Therapeutics, Inc.
27 Jun 2016
Director
Bought
150,000
$2.10M
8.9%
FATE FATE THERAPEUTICS INC
4 Oct 2013
Director
Bought
804,112
$4.82M
49.0%
FATE FATE THERAPEUTICS INC
4 Oct 2013
Director
Bought
15,672
$94.03K
0.6%
FATE FATE THERAPEUTICS INC
4 Oct 2013
Director
Bought
8,041
$48.25K
0.3%
FATE FATE THERAPEUTICS INC
4 Oct 2013
Director
Bought
5,508
$33.05K
0.2%
35 decisions on file.